Evidence map›Paper›PMID 28474973›Full record

ArticlePediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

Hepatic Hilar Lymph Node Reactivity at Kasai Portoenterostomy for Biliary Atresia: Correlations With Age, Outcome, and Histology of Proximal Biliary Remnant.

K E Bove, R Sheridan, L Fei, R Anders, C T Chung, O W Cummings, M J Finegold, L Finn, S Ranganathan, G Kim and 10 more

Open access · greenAbstract read
In one paragraph

Article in Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 2 countries.

K E Bove1 Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
R Sheridan1 Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
L Fei2 Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
R Anders3 Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
C T Chung4 Division of Pathology, The Hospital for Sick Children, Toronto, Canada.
O W Cummings5 Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana.
M J Finegold6 Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.
L Finn7 Department of Pathology, Seattle Children's Hospital, Seattle, Washington, USA.
S Ranganathan8 Department of Pathology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA.
G Kim9 Department of Anatomic Pathology, University of California, San Francisco, California, USA.
M Lovell10 Department of Pathology, Children's Hospital Colorado, Aurora, Colorado, USA.
M S Magid11 Department of Pathology, Kravis Children's Hospital, Mount Sinai Medical Center, New York, New York, USA.
H Melin-Aldana12 Department of Pathology, Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, USA.
P Russo13 Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
B Shehata14 Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
L Wang15 Department of Pathology, Children's Hospital Los Angeles, Los Angeles, California, USA.
F White16 Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
Z Chen17 Quest Diagnostics, Health Informatics, Madison, New Jersey, USA.
C Spino18 Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
J C Magee19 Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Cincinnati Children's Hospital Medical Center · USUniversity of Michigan–Ann Arbor · USChildren's Healthcare of Atlanta · USChildren's Hospital Colorado · USChildren's Hospital of Los Angeles · USChildren's Hospital of Philadelphia · USChildren's Hospital of Pittsburgh · USHospital for Sick Children · CAIndiana University – Purdue University Indianapolis · USJohns Hopkins University · USLurie Children's Hospital · USMount Sinai Medical Center · USQuest Diagnostics (United States) · USSeattle Children's Hospital · USTexas Children's Hospital · USUniversity of California, San Francisco · USWashington University in St. Louis · US

Funding

Childhood Liver Disease Research Network Data Coordinating CenterU01DK062456 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MAGEE, JOHN C, MERION, ROBERT M · 2002 to 2019
$36.8M
Childhood Liver Disease Research Network Data Coordinating CenterU24DK062456 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHN C MAGEE · 2019 to 2026
$18.9M
Etiology and Treatment of Biliary Atresia and INHU01DK062453 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI RONALD J. SOKOL · 2002 to 2026
$13.5M
Clinical Center for Cholestatic Liver Disease in ChildrenU01DK062497 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2002 to 2026
$13.2M
VCU-Atlanta Center for the Childhood Liver Disease Research Network (ChiLDReN)U01DK062470 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI SAUL J. KARPEN · 2005 to 2026
$12.7M
Mid-Atlantic BANH Consortium SiteU01DK062481 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Binita Maya Kamath, Kathleen Mary Loomes · 2002 to 2026
$9.2M
Macrophage Cell Subset Specific Biomarkers for Disease Prognosis in Biliary AtresiaU01DK062436 · NIDDK · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI ALONSO, ESTELLA M. · 2002 to 2023
$7.0M
The Pittsburgh Cholestatic Liver Disease ConsortiumU01DK062466 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HORSLEN, SIMON · 2002 to 2023
$6.3M
Continuation of ChiLDReN, the Childhood Liver Disease Research Network: Indiana UniversityU01DK084536 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI MOLLESTON, JEAN PAPPAS · 2009 to 2023
$5.9M
Continuation of the Childhood Liver Disease Research Network Seattle Clinical CenterU01DK084575 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Pamela Valentino · 2009 to 2026
$5.2M
Limited Competition for the Continuation of the Childhood Liver Disease Research Network (ChilLDRen) Clinical Centers.U01DK084538 · NIDDK · CHILDREN'S HOSPITAL OF LOS ANGELES · PI KOHLI, ROHIT · 2009 to 2023
$4.8M
Childhood Liver Disease Research Network (ChiLDReN) - UCSF (CC)U01DK062500 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENTHAL, PHILIP · 2002 to 2023
$4.0M
NIDDK NIH HHS U01 DK062436NIDDK NIH HHS U01 DK062445NIDDK NIH HHS U01 DK062452NIDDK NIH HHS U01 DK062453NIDDK NIH HHS U01 DK062456NIDDK NIH HHS U01 DK062466NIDDK NIH HHS U01 DK062470NIDDK NIH HHS U01 DK062481NIDDK NIH HHS U01 DK062497NIDDK NIH HHS U01 DK062500NIDDK NIH HHS U01 DK062503NIDDK NIH HHS U01 DK084536NIDDK NIH HHS U01 DK084538NIDDK NIH HHS U01 DK084575NIDDK NIH HHS U24 DK062456
6 · The paper itself

Abstract

We hypothesized that if infection is the proximate cause of congenital biliary atresia, an appropriate response to antigen would occur in lymph nodes contiguous with the biliary remnant. We compared the number of follicular germinal centers (GC) in 79 surgically excised hilar lymph nodes (LN) and 27 incidentally discovered cystic duct LNs in 84 subjects at the time of hepatic portoenterostomy (HPE) for biliary atresia (BA) to autopsy controls from the pancreaticobiliary region of non-septic infants >3 months old at death. All 27 control LN lacked GC, a sign in infants of a primary response to antigenic stimulation. GC were found in 53% of 106 LN in 56 of 84 subjects. Visible surgically excised LN contiguous with the most proximal biliary remnants had 1 or more well-formed reactive GC in only 26/51 subjects. Presence of GC and number of GC/LN was unrelated to age at onset of jaundice or to active fibroplasia in the biliary remnant but was related to older age at HPE. Absent GC in visible and incidentally removed cystic duct LNs predicted survival with the native liver at 2 and 3 years after HPE, P = .03, but significance was lost at longer intervals. The uncommon inflammatory lesions occasionally found in remnants could be secondary either to bile-induced injury or secondary infection established as obstruction evolves. The absence of consistent evidence of antigenic stimulation in LN contiguous with the biliary remnant supports existence of at least 1 major alternative to infection in the etiology of biliary atresia.

Indexed as

Portoenterostomy, HepaticAge FactorsBiliary AtresiaCase-Control StudiesFemaleFollow-Up StudiesGerminal CenterHumansInfantInfant, NewbornLiverMaleTreatment Outcomebiliary atesiabiliary remnantgerminal center reactionHilar lymph nodeKasai procedureoutcome

Identifiers

PMID28474973
PMCPMC7986481
OpenAlexW2778600632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.